Company Led Recall: Mawdsley-Brooks & Company Limited, Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection, CLMR(23)A/01
MDR Number: MDR 234-11/22
Company name: Mawdsley-Brooks & Company Limited
Product description:
Fluphenazin-neuraxpharm® D 100 mg/ml Solution for Injection [unlicensed medicine]
Batch Number |
Expiry Date |
Pack Size |
First Distributed |
200686 |
01/2024 |
5 x 1ml |
21/05/2021 |
Fluphenazin-neuraxpharm® D 25mg/ml Solution for Injection [unlicensed medicine]
Batch Number | Expiry Date | Pack Size | First Distributed |
202052 | 01/2024 | 5 x 1ml | 16/07/2021 |
Brief description of problem:
Specific batches of product are recalled as a precautionary measure due to validation tests demonstrating the leaching of filter additives that are above the acceptable limit.
This recall is being issued as a company-led medicines recall as the products are only supplied to limited number of customers, and the manufacturer has full traceability of the product’s distribution.
Advice to Pharmacies:
Remaining stock of the above batches should be quarantined and returned to Mawdsleys directly
Company contacts for further information:
For medical information enquiries, please contact Michelle Biggs at michelle.biggs@mawdsleys.co.uk
For stock information enquiries, please contact Andrea Dunlop at andrea.dunlop@mawdsleys.co.uk